MENU
+Compare
RPRX
Stock ticker: NASDAQ
AS OF
Jun 5, 04:59 PM (EDT)
Price
$33.76
Change
+$0.32 (+0.96%)
Capitalization
14.09B

RPRX Royalty Pharma plc Forecast, Technical & Fundamental Analysis

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties... Show more

RPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for RPRX with price predictions
Jun 04, 2025

RPRX in upward trend: price rose above 50-day moving average on May 15, 2025

RPRX moved above its 50-day moving average on May 15, 2025 date and that indicates a change from a downward trend to an upward trend. In of 54 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 60 cases where RPRX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on June 04, 2025. You may want to consider a long position or call options on RPRX as a result. In of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for RPRX just turned positive on June 04, 2025. Looking at past instances where RPRX's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for RPRX crossed bullishly above the 50-day moving average on May 07, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RPRX advanced for three days, in of 278 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 169 cases where RPRX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RPRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

RPRX broke above its upper Bollinger Band on May 16, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.107) is normal, around the industry mean (16.306). P/E Ratio (13.649) is within average values for comparable stocks, (59.921). Projected Growth (PEG Ratio) (2.995) is also within normal values, averaging (2.224). Dividend Yield (0.026) settles around the average of (0.040) among similar stocks. P/S Ratio (8.703) is also within normal values, averaging (265.014).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RPRX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
RPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

RPRX is expected to report earnings to rise 154.98% to $1.05 per share on August 06

Royalty Pharma plc RPRX Stock Earnings Reports
Q2'25
Est.
$1.05
Q1'25
Missed
by $0.66
Q4'24
Missed
by $0.63
Q3'24
Missed
by $0.01
Q2'24
Est.
$0.97
The last earnings report on May 08 showed earnings per share of 41 cents, missing the estimate of $1.07. With 1.11M shares outstanding, the current market capitalization sits at 14.09B.
A.I.Advisor
published Dividends

RPRX is expected to pay dividends on June 10, 2025

Royalty Pharma plc RPRX Stock Dividends
A dividend of $0.22 per share will be paid with a record date of June 10, 2025, and an ex-dividend date of May 16, 2025. The last dividend of $0.22 was paid on March 10. Read more...
A.I. Advisor
published General Information

General Information

a provider of drug development services

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
110 East 59th Street
Phone
+1 212 883-0200
Employees
89
Web
https://www.royaltypharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
EDU.X0.1406180.000644
+0.46%
Open Campus cryptocurrency
QUICK.X23.1508670.087799
+0.38%
QuickSwap [Old] cryptocurrency
HOT.X0.000976-0.000027
-2.70%
Holo cryptocurrency
MKR.X1779.676000-88.331180
-4.73%
Maker cryptocurrency
IMX.X0.548379-0.029331
-5.08%
Immutable cryptocurrency

RPRX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RPRX has been loosely correlated with AXON. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if RPRX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RPRX
1D Price
Change %
RPRX100%
+0.45%
AXON - RPRX
48%
Loosely correlated
+2.76%
MDGL - RPRX
31%
Poorly correlated
-1.79%
ARRY - RPRX
30%
Poorly correlated
-0.43%
DTIL - RPRX
29%
Poorly correlated
-0.97%
QURE - RPRX
29%
Poorly correlated
-1.32%
More